We are international
Donate
TEXT SIZE   
   back

Dr. Jakubowiak - Targeted Therapy Against Clonogenic Myeloma Cells with Iodine I-131 Tositumomab (Bexxar™).
Andrzej Jakubowiak, MD
University of Michigan Cancer Center
Ann Arbor, MI
01.08.08


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles